Cargando…
T‐cell depleted HLA‐haploidentical HSCT in a child with neuromyelitis optica
Neuromyelitis optica is an immune‐mediated disease characterized by a relapsing course, resulting in progressive disability. In children, given the long life expectancy, a disease‐modifying treatment could be particularly desirable. Unfortunately, the currently available treatment strategies with th...
Autores principales: | Ceglie, Giulia, Papetti, Laura, Figà Talamanca, Lorenzo, Lucarelli, Barbarella, Algeri, Mattia, Gaspari, Stefania, Li Pira, Giuseppina, Colafati, Giovanna‐Stefania, Montanari, Mauro, Valeriani, Massimiliano, Locatelli, Franco, Merli, Pietro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801170/ https://www.ncbi.nlm.nih.gov/pubmed/31529689 http://dx.doi.org/10.1002/acn3.50843 |
Ejemplares similares
-
Hematopoietic Stem Cell Transplantation in Neuromyelitis Optica-Spectrum Disorders (NMO-SD): State-of-the-Art and Future Perspectives
por: Ceglie, Giulia, et al.
Publicado: (2020) -
Pediatric Neuromyelitis Optica Spectrum Disorder: Case Series and Literature Review
por: Ferilli, Michela Ada Noris, et al.
Publicado: (2021) -
TCRαβ/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders
por: Merli, Pietro, et al.
Publicado: (2022) -
Mobilization of healthy donors with plerixafor affects the cellular composition of T-cell receptor (TCR)-αβ/CD19-depleted haploidentical stem cell grafts
por: Rutella, Sergio, et al.
Publicado: (2014) -
Novel Therapeutic Approaches to Familial HLH (Emapalumab in FHL)
por: Merli, Pietro, et al.
Publicado: (2020)